SEREMBAN, MALAYSIA--(Marketwired - Sep 14, 2017) - Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, expanded its regional ...

KNOXVILLE, KY--(Marketwired - November 05, 2015) - Fresenius Medical Care North America (FMCNA), the continent's leading provider of kidney care products and services, announced today that key ...

HONG KONG--(BUSINESS WIRE)--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today presented its advances in home dialysis solutions ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Fresenius Medical Care North America’s Delflex peritoneal dialysis solutions in Biofine, a ...

The Food and Drug Administration has approved DELFLEX peritoneal dialysis solutions in Biofine, an innovative bag material made by Fresenius Medical Care North America’s Renal Therapies Group.

Fresenius has launched a virtual reality based training programme for people undergoing home dialysis in Germany, its home market, ahead of a rollout in other countries later this year. The VR system ...

Fresenius Medical Care, a major provider of renal disease products, will start the new year with a new global chief medical ...

Please provide your email address to receive an email when new articles are posted on . “The Kinexus platform is an important step to further accelerating the adoption of home dialysis by enabling ...

We expect DaVita DVA and Fresenius Medical Care FMS/FME to benefit as higher-margin home dialysis treatments gain share, with growth of nearly 8% set to outpace in-center dialysis growth of roughly ...

WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care Renal Therapies Group (RTG) , the continent’s leading provider of kidney care products, announced today that Dr. Jose A. Diaz-Buxo, Chief ...

Fresenius has significant market share in dialysis, but reimbursement pressures in the U.S. are a significant challenge. Fresenius provides both hemodialysis services (for which private insurers and ...

NXTM is trading at a ~20% gross spread to its $30 cash offer from Fresenius. Regulatory concerns and deteriorating business fundamentals are the reason for the wide spread. Despite clear regulatory ...